Iodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer. [electronic resource]
Producer: 20150930Description: 1771-9 p. digitalISSN:- 1945-7197
- Anilides -- pharmacology
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Autoantigens -- genetics
- Carcinoma, Papillary -- drug therapy
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Glucose Transporter Type 1 -- genetics
- Glucose Transporter Type 3 -- genetics
- Humans
- Iodide Peroxidase -- genetics
- Iron-Binding Proteins -- genetics
- Microfilament Proteins -- genetics
- Muscle Proteins -- genetics
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- pharmacology
- Phosphorylation -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- genetics
- Proto-Oncogene Proteins c-ret -- genetics
- Pyridines -- pharmacology
- Receptors, Thyrotropin -- genetics
- Signal Transduction -- drug effects
- Sorafenib
- Symporters -- genetics
- Thyroid Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.